SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of Earliest Event Reported): February 16, 2006
Commission file number 001-12215
Quest Diagnostics Incorporated
1290 Wall Street West
Lyndhurst, NJ 07071
(201) 393-5000
Delaware
(State of Incorporation)
16-1387862
(I.R.S. Employer Identification Number)
| Item 5.02 | Departure of Directors or Principal Officers; Election
of Directors; Appointment of Principal Officers |
On February 16, 2006, during a regularly scheduled and properly called meeting of the board of directors (the "Board") of Quest Diagnostics Incorporated (the "Company"), Mr. James F. Flaherty III, a director of the Company, notified the Board of his decision not to stand for reelection as a director of the Company at the Company's 2006 Annual Meeting of Stockholders. Mr. Flaherty's term as a director will expire on the date of the 2006 Annual Meeting of Stockholders which is currently scheduled for May 4, 2006. Mr. Flaherty's decision was not the result of any disagreement with the Company.
Signature
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| February 22, 2006 | ||||
| QUEST DIAGNOSTICS INCORPORATED | ||||
| By: | /s/ Leo C. Farrenkopf, Jr. | |||
| Leo C. Farrenkopf, Jr. Assistant General Counsel and Assistant Corporate Secretary |
||||